Implantable System for Remodulin

Pump, Infusion, Implanted, Programmable

FDA Premarket Approval P140032

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the implantable system for remodulin®. This device is indicated for adult patients with class i, ii and iii pulmonary arterial hypertension (pah) receiving intravenous delivery of remodulin.

DeviceImplantable System for Remodulin
Classification NamePump, Infusion, Implanted, Programmable
Generic NamePump, Infusion, Implanted, Programmable
ApplicantMedtronic, Inc.
Date Received2014-12-23
Decision Date2017-12-22
Notice Date2018-01-09
PMAP140032
SupplementS
Product CodeLKK
Docket Number17M-6984
Advisory CommitteeGeneral Hospital
Expedited ReviewNo
Combination Product Yes
Applicant Address Medtronic, Inc. 710 Medtronic Parkway Ne minneapolis, MN 55432-5604
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P140032Original Filing
S074 2021-08-04 Normal 180 Day Track No User Fee
S073 2021-06-21 30-day Notice
S072 2021-05-28 30-day Notice
S071 2021-05-04 30-day Notice
S070 2021-04-09 30-day Notice
S069 2021-04-08 30-day Notice
S068 2021-03-08 30-day Notice
S067 2021-02-25 30-day Notice
S066
S065 2020-12-11 30-day Notice
S064 2020-11-18 30-day Notice
S063 2020-11-03 30-day Notice
S062 2020-10-20 30-day Notice
S061 2020-08-26 Real-time Process
S060 2020-08-11 30-day Notice
S059 2020-08-07 30-day Notice
S058
S057
S056 2020-05-11 30-day Notice
S055 2020-04-24 30-day Notice
S054 2020-04-16 30-day Notice
S053 2020-04-09 30-day Notice
S052 2020-03-23 30-day Notice
S051 2020-03-11 30-day Notice
S050 2020-03-09 30-day Notice
S049
S048 2019-12-23 Special (immediate Track)
S047
S046 2019-12-10 30-day Notice
S045 2019-12-10 30-day Notice
S044 2019-11-25 30-day Notice
S043 2019-11-15 30-day Notice
S042 2019-09-27 30-day Notice
S041 2019-08-30 30-day Notice
S040 2019-08-09 30-day Notice
S039 2019-08-08 30-day Notice
S038 2019-07-26 30-day Notice
S037 2019-07-16 30-day Notice
S036
S035 2019-06-06 30-day Notice
S034 2019-05-06 30-day Notice
S033 2019-04-26 30-day Notice
S032
S031 2019-04-01 30-day Notice
S030 2019-03-07 30-day Notice
S029 2019-02-28 30-day Notice
S028 2019-02-27 30-day Notice
S027 2019-02-22 30-day Notice
S026 2019-01-09 30-day Notice
S025 2018-12-26 Real-time Process
S024
S023 2018-12-11 30-day Notice
S022 2018-10-30 Special (immediate Track)
S021 2018-10-19 30-day Notice
S020 2018-08-20 Normal 180 Day Track
S019 2018-08-15 30-day Notice
S018
S017 2018-07-25 Special (immediate Track)
S016 2018-07-17 30-day Notice
S015 2018-07-02 30-day Notice
S014 2018-06-18 30-day Notice
S013 2018-06-01 Real-time Process
S012 2018-05-24 30-day Notice
S011 2018-05-16 30-day Notice
S010 2018-05-16 30-day Notice
S009 2018-05-07 30-day Notice
S008 2018-05-07 30-day Notice
S007 2018-05-02 30-day Notice
S006 2018-04-20 Special (immediate Track)
S005 2018-04-18 Normal 180 Day Track No User Fee
S004 2018-04-16 30-day Notice
S003 2018-03-12 30-day Notice
S002 2018-02-01 Normal 180 Day Track
S001 2018-01-22 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.